THE CORPORATE LIBRARY

Related Party Transactions and Outside Related Director Information

BroadVision, Inc. (BVSN.PK)

7/18/2006 Proxy Information

In 1996, Mr. Stieger established BroadVision’s European operations.

Since January 1, 2001, there has not been, nor is there currently proposed, any transaction or series of similar transactions to which the Company was or is a party in which the amount involved exceeds or exceeded $60,000 and in which any director, executive officer or beneficial holder of more than 5% of any class of the Company’s voting securities or members of such person’s immediate family had or will have a direct or indirect material interest other than as described under “Management” and as described below. All future transactions between the Company and any of its directors, executive officers or related parties will be subject to the review and approval of the Company’s nominating and corporate governance committee, compensation committee or other committee comprised of independent, disinterested directors.

On November 18, 2005, the Company’s Chief Executive Officer and largest stockholder, Dr. Pehong Chen, acquired all of the Company’s outstanding Senior Subordinated Convertible Notes. Including accrued interest, the Notes represented approximately $15.5 million in debt obligations as of December 20, 2005. In order to relieve the Company from the liquidity challenges presented by the Notes, Dr. Chen agreed to cancel all amounts owed under the Notes in exchange for 34,500,000 shares of BroadVision common stock at an effective price per share of $0.45, representing a 25% discount to the December 20, 2005 closing price of BroadVision common stock of $0.60 per share. This is referred to as the “Note Conversion”. On March 8, 2006, the Company issued 34,500,000 new shares of common stock to Dr. Chen that, as of March 15, 2006, represents approximately 49.9% of the Company’s total outstanding common stock immediately following such issuance.

Director and Officer Indemnification

The Company’s amended and restated certificate of incorporation contains provisions limiting the liability of directors. In addition, the Company has entered into agreements to indemnify its directors and executive officers to the fullest extent permitted under Delaware law. We have entered into indemnity agreements with certain officers and directors that provide, among other things, that the Company will indemnify such officer or director, under the circumstances and to the extent provided for in such agreement, for expenses, damages, judgments, fines and settlements he or she may be required to pay in actions or proceedings to which he or she is or may be made a party be reason of his or her position as a director, officer or other agent of the Company, and otherwise to the full extent permitted under Delaware law and the Company’s Bylaws.

4/22/2005 Proxy Information

Since January 1, 2001, there has not been, nor is there currently proposed, any transaction or series of similar transactions to which the Company was or is a party in which the amount involved exceeds or exceeded $60,000 and in which any director, executive officer or beneficial holder of more than 5% of any class of the Company’s voting securities or members of such person’s immediate family had or will have a direct or indirect material interest other than as described under “Management” and as described below. All future transactions between the Company and any of the Company’s directors, executive officers or related parties will be subject to the review and approval of the Company Audit Committee or other committee comprised of independent, disinterested directors.

4/30/2003 and 4/29/2004 Proxy Information

No related party transactions or special relationships reported for this company. Director relationships marked "Outside Related" at this firm will most often be former executives of the company. Additional information regarding these relationships will be added during our regular updates.